Chance H Bloomer

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Top Venues

Therapeutic advances in medical oncology

Case reports in immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Kimberly M Burcher, Chance H Bloomer, Elena Gavrila, John M Kalada, Mark J Chang, Rediet R Gebeyehu, Alexander H Song, Lara M Khoury, Thomas W Lycan, Rebecca Kinney, Ralph D'Agostino, Paul M Bunch, Kirtikar Shukla, Pierre Triozzi, Cristina M Furdui, Wei Zhang, Mercedes Porosnicu
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer. Therapeutic advances in medical oncology 16 (2024)
Kimberly M Burcher, Chance H Bloomer, Elena Gavrila, John M Kalada, Mark J Chang, Rediet R Gebeyehu, Alexander H Song, Lara M Khoury, Thomas W Lycan, Rebecca Kinney, Ralph D'Agostino, Paul M Bunch, Kirtikar Shukla, Pierre Triozzi, Cristina M Furdui, Wei Zhang, Mercedes Porosnicu
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer. Therapeutic advances in medical oncology 16 (2024)
Kimberly M Burcher, Chance H Bloomer, Elena Gavrila, John M Kalada, Mark J Chang, Rediet R Gebeyehu, Alexander H Song, Lara M Khoury, Thomas W Lycan, Rebecca Kinney, Ralph D'Agostino, Paul M Bunch, Kirtikar Shukla, Pierre Triozzi, Cristina M Furdui, Wei Zhang, Mercedes Porosnicu
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer. Therapeutic advances in medical oncology 16 (2024)
Chance H Bloomer, Elena Gavrila, Kimberly M Burcher, John M Kalada, Mark J Chang, Rediet R Gebeyehu, Elsabeth Asare, Lara M Khoury, Rebecca Kinney, Bart Frizzell, Christopher A Sullivan, Paul M Bunch, Mercedes Porosnicu
Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature. Therapeutic advances in medical oncology 15 (2023)
Chance H Bloomer, Elena Gavrila, Kimberly M Burcher, John M Kalada, Mark J Chang, Rediet R Gebeyehu, Elsabeth Asare, Lara M Khoury, Rebecca Kinney, Bart Frizzell, Christopher A Sullivan, Paul M Bunch, Mercedes Porosnicu
Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature. Therapeutic advances in medical oncology 15 (2023)
Chance H Bloomer, Rahul V Annabathula, Vanya Aggarwal, Bharathi Upadhya, Thomas W Lycan
A Case Report of Immune Checkpoint Inhibitor-Induced Aortitis Treated with Tocilizumab. Case reports in immunology 2022 (2022)